Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors
about
Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in CancerHallmarks of glycosylation in cancerThe role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applicationsChemical Lectinology: Tools for Probing the Ligands and Dynamics of Mammalian Lectins In VivoGalectin-Binding O-Glycosylations as Regulators of MalignancyPrinciples of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in diseaseRegulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatmentGalectins in epithelial functionsGalectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac CellsCanonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction.Galectin-3 in angiogenesis and metastasis.The Role of Galectin-1 in Cancer Progression, and Synthetic Multivalent Systems for the Study of Galectin-1Golgi self-correction generates bioequivalent glycans to preserve cellular homeostasis.Expression and functions of galectin-7 in ovarian cancer.Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells.Serum glycopattern and Maackia amurensis lectin-II binding glycoproteins in autism spectrum disorderGlycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies.Sensitization of glioblastoma tumor micro-environment to chemo- and immunotherapy by Galectin-1 intranasal knock-down strategyGalectin-1 expression imprints a neurovascular phenotype in proliferative retinopathies and delineates responses to anti-VEGFEffects of altered sialic acid biosynthesis on N-linked glycan branching and cell surface interactionsGalectin-1 links tumor hypoxia and radiotherapy.Endothelial cell metabolism: parallels and divergences with cancer cell metabolismGalectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.Interaction of platelet endothelial cell adhesion molecule (PECAM) with α2,6-sialylated glycan regulates its cell surface residency and anti-apoptotic role.Glycobiology of ocular angiogenesis.Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.Folding and function in α/β-peptides: targets and therapeutic applications.Proteins associated with pancreatic cancer survival in patients with resectable pancreatic ductal adenocarcinoma.Fingerprinting of galectins in normal, P. aeruginosa-infected, and chemically burned mouse corneasControl of angiogenesis by galectins involves the release of platelet-derived proangiogenic factorsSize does not matter: commensal microorganisms forge tumor-promoting inflammation and anti-tumor immunity.Protein glycosylation in cancer.LIF upregulates poFUT1 expression and promotes trophoblast cell migration and invasion at the fetal-maternal interfaceStructural, functional, and evolutionary aspects of galectins in aquatic mollusks: From a sweet tooth to the Trojan horse.The luteotrophic function of galectin-1 by binding to the glycans on vascular endothelial growth factor receptor-2 in bovine luteal cells.Unlocking Cancer Glycomes from Histopathological Formalin-fixed and Paraffin-embedded (FFPE) Tissue Microdissections.Computational investigation of sphingosine kinase 1 (SphK1) and calcium dependent ERK1/2 activation downstream of VEGFR2 in endothelial cells.Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic RetinopathyUnmasking of CD22 Co-receptor on Germinal Center B-cells Occurs by Alternative Mechanisms in Mouse and Man.
P2860
Q26742115-BE5506EE-9098-47E1-BCD3-FF36FD057945Q26744538-5E404B95-4D5F-4390-A4B8-B8DA48CCE7B3Q26752363-601D3DEC-3645-4709-A995-08659845F3A1Q26779166-1E71E88A-2899-4A12-AAAB-2D58FDC0979FQ26800514-8E2E9F9E-2891-4B77-A9A8-A6DBFAB1BD78Q26801724-A2EACEF2-6FE2-4FCD-AE68-B9CEE73AD5D0Q26859449-FA153DA1-4E37-439C-A3B5-33E1E44235EFQ26991865-1C83375D-0946-4E4B-8318-791E4E8E0FB3Q27000800-87667BC7-B459-42AF-ADF4-EC72D1408C25Q27303934-BD87CE00-D3C4-4797-B191-AC87A4A881DBQ27342723-CE364C8A-EC88-41E1-AD3C-33C31AB931F7Q27687444-F79FCD8F-B5CA-4284-8D6C-F40EA5919BE7Q28075523-64192A85-62BA-4C77-9FB7-8CA10BEC0FF3Q30379238-A33C1EDE-6235-4E81-BA32-208F5DF442A1Q30594259-FDD6ED16-BB4A-415D-BCF6-BD8ECA429E10Q33569458-4773F1F1-C7EA-4099-9464-5454ABC56A72Q33651921-59BD3AE4-F229-4B1E-92E9-4B8638D9EFA4Q33659849-F9957632-721B-4410-B0C5-143D562AAE5CQ33683101-4825ECCF-2A77-40F1-A56D-BB9E36861E28Q33779141-DA951730-8DFF-45FB-8B9B-496FA49234AFQ33781368-6CCAE465-BD0A-45B8-9CC0-063B39747E23Q34129297-481FF831-64DC-4B8C-9D1F-593AF1C615AAQ34228247-235CF67D-0949-4A32-9AFC-5BABBB9557A5Q34258192-F9EA1077-743E-4D14-9E78-BC8417479D53Q34283441-F5CB8679-5C41-4411-8E19-9657522BE9B4Q34414227-4A590830-E1C1-41F3-BF4E-07474EF1329DQ34438522-7992613B-511C-4957-8F37-67212B9515D8Q34483276-193B693C-A965-4F38-AC17-BD94F65B6AB0Q34797866-0FA7949A-29FF-4420-B135-7F696F2EA530Q34999835-C3DB4A76-B513-44C6-BD90-E59A219479DDQ35161608-A62409F9-B97E-4B45-B2B8-D80C03A30560Q35376137-BE26B55D-D90B-4357-9E55-7A01CF798BDBQ35413473-7E335D61-D8AA-4385-8DCB-72573D0909AAQ35679536-E2167A3D-EBCC-438D-B6E0-E8CD225FBEA6Q35875778-C12278A6-FE8F-4621-9601-368EA7B0882BQ36215122-FE9C08AE-E14E-4CBE-A16F-5F41FF1F6689Q36260470-674972C2-69F3-4943-8130-6E2E317F9E7EQ36273980-192F0C44-6E99-4FD3-9EAB-9C16D3CCA6DDQ36357723-0FE49CA0-B920-459A-BDAB-2D4DB7F869FDQ36444166-2BB3720F-19A8-4AD4-B72C-550BD927BD23
P2860
Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@ast
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@en
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@en-gb
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@nl
type
label
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@ast
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@en
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@en-gb
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@nl
prefLabel
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@ast
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@en
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@en-gb
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@nl
P2093
P3181
P1433
P1476
Glycosylation-dependent lectin ...... in anti-VEGF refractory tumors
@en
P2093
Carlos Bais
Diego O Croci
Enrique A Mesri
Gabriel A Rabinovich
Ivan D Mascanfroni
Jing Ouyang
Juan J García-Vallejo
Juan P Cerliani
Julio J Caramelo
Margaret A Shipp
P304
P3181
P356
10.1016/J.CELL.2014.01.043
P407
P577
2014-02-13T00:00:00Z